Earlier studies showed association of the human SAH (Spontaneously hypertensive rat-clone A-Hypertension associated) gene with hypertension and obesity. Left ventricular mass index (LVMI) increases with blood pressure and body mass index. In a family-based population study (54.5% women; mean age, 43.1 years), we measured LVMI, mean wall thickness (MWT) and the left ventricular internal diameter (LVID) at end-diastole in 699 non-Slavic and 493 Slavic participants. In multivariable-adjusted analyses, we investigated phenotype-genotype associations (SAH GÀ1606A and À962ins/del polymorphisms), while accounting for confounders and relatedness. Non-Slavic À1606GG homozygotes had a slightly greater LVID than À1606A allele carriers (48.6 vs. 48.0 mm; P¼0.08). However, the between-family component of the variance in LVID was significant (P¼0.005), suggesting that population stratification might explain the latter finding. Non-Slavic À962del carriers had higher LVMI (91.1 vs. 88.5 g m À2 ; P¼0.03) and MWT (9.61 vs. 9.44 mm; P¼0.03) than À962ins homozygotes. Transmission of the À962del to non-Slavic offspring was also associated with higher MWT (P¼0.03). In Slavic participants, in the absence of population stratification (PX0.69), À1606GG homozygotes had lower LVMI (96.5 vs. 102.3 g m À2 ; P¼0.004) and lower MWT (10.1 vs. 10.5 mm; P¼0.003) than À1606A carriers. Sensitivity analyses showed that the latter associations were confined to founders. Transmission of the À962del allele to Slavic offspring was associated with lower MWT (P¼0.007). In conclusion, LVMI and MWT, two phenotypes that are jointly influenced by blood pressure and obesity, might be related to variation in the human SAH gene.
INTRODUCTION
The expression of SAH (Spontaneously hypertensive rat-clone AHypertension-associated) gene is markedly higher in the kidneys of spontaneously hypertensive rats compared with normotensive WistarKyoto control rats. 1 In rats, SAH is expressed mainly in the proximal renal tubules. 2 The human SAH gene is located on chromosome 16p13.11. 3 Several earlier studies suggested association of the human SAH gene with hypertension and related metabolic phenotypes, such as obesity, 4 hypercholesterolemia 5 and hypertriglyceridemia. 6 However, we recently analyzed blood pressure, measures of obesity, serum lipids and blood glucose as continuous phenotypes in 2603 relatives from 560 families and 31 unrelated subjects randomly recruited from six populations in the framework of the European Project on Genes in Hypertension (EPOCH). We genotyped our study population for SAH GÀ1606A and À962ins/del. In spite of sufficient statistical power, none of the phenotype-genotype associations approached statistical significance. 7 Left ventricular mass index (LVMI) increases with blood pressure and body mass index. 8 This phenotype might therefore more readily pick up association with variation in the SAH gene. In this study, we explored possible association between left ventricular structure and the GÀ1606A and À962ins/del polymorphisms in the human SAH gene.
METHODS

Study population
We conducted the European Project on Genes in Hypertension according to the principles outlined in the Helsinki declaration for investigations in human subjects. 9 The Ethics Committee of each institution approved the study. In seven European countries, investigators randomly enrolled nuclear and extended families of White Caucasian ethnicity. Four centers took part in the substudy on echocardiography 10, 11 and together enrolled 1522 subjects in Kraków (Poland; n¼325), Novosibirsk (Russian Federation; n¼301), Mirano (Italy; n¼345) and Hechtel-Eksel (Belgium; n¼551). The overall response rate was 67.8%. All participants gave informed written consent. We excluded 330 subjects from analysis, (1) because ECGs were either unavailable (n¼96) or of insufficient quality (n¼52), (2) because participants had left ventricular dysfunction due to myocardial infarction or valvular disorders (n¼52), (3) because of lack of measurements required for our analysis (n¼58), (4) because DNA failed to amplify (n¼63) (5) or because of inconsistency in Mendelian segregation (n¼9). Thus, the number of subjects statistically analyzed totaled 1192.
Echocardiographic measurements
In each center, one highly experienced observer performed all ECGs, using a commercially available device equipped with a 3.5-MHz transducer. 10, 11 With subjects in left decubitus and breathing normally, the observers obtained Mmode echocardiograms of the left ventricle from the parasternal long-axis view under control of the two-dimensional image. They positioned the ultrasound beam just below the mitral valve at the level of the posterior chordae tendineae. The echocardiographic examinations were recorded on videotape and analyzed offline. The observers measured left ventricular internal diameter (LVID) and interventricular septal and posterior wall thickness at end-diastole, according to the recommendations of the American Society of Echocardiography. 12 Mean wall thickness (MWT) was half of the sum of the interventricular septal and posterior wall thickness at end-diastole. Left ventricular end-diastolic dimensions were used to compute left ventricular mass by an anatomically validated formula. 12 LVMI was left ventricular mass divided by body surface area, calculated as body weight 0.425 (in kg)Âbody height 0.725 (in cm)Â0.007184. For statistical analysis, the measurements of three cardiac cycles were averaged.
Other measurements
With the subjects seated for at least 5 min, trained nurses obtained five consecutive blood pressure readings at the examination center. The blood pressure phenotype was the average of these five readings. Hypertension was a blood pressure of X140 mm Hg systolic or X90 mm Hg diastolic or the use of blood pressure lowering medications. Body mass index was weight in kilograms divided by the square of height in meters. We used a standardized questionnaire to collect information on each subject's medical history, smoking and drinking habits and intake of medications. The participants collected a 24-h urine sample in a wide-neck plastic container for the measurement of sodium, potassium and creatinine. If urinary volume or creatinine excretion were outside published limits, 13 the urinary measurements were considered to be missing and subjects were excluded from analysis.
Determination of genotypes
We extracted genomic DNA from WBCs, using the standard kits (Qiagen, Hilden, Germany). For genotyping, we used restriction fragment length polymorphism analysis of the respective PCR products at the frequent polymorphic loci GÀ1606A (restriction enzyme KspAI) and À962ins/del (XapI). Because the C-1808T was completely associated with GÀ1606A, 14 we did not genotype for this variant.
Using the published sequence of human SAH gene (accession number AC004381.1), primers were designed to amplify both fragments covering the appropriate SAH polymorphic sites. The PCR amplification was carried out in a 20-ml volume, containing 5 ng genomic DNA, 10 and 25 pmol l À1 of each primer (for both fragments, respectively), 2.5 mmol l À1 MgCl 2 , 200 mol l À1 of each dNTP, 5 mmol l À1 betaine and 1 U AmpliTaq polymerase (Rapidozym, Berlin, Germany). The PCR was performed initially for 3 min at 94 1C and followed by 35 cycles, each with 45 s at 94 1C, 45 s at 54 and 56 1C (depending on primer sequence), 60 s at 72 1C and final elongation of 10 min at 72 1C.
In the presence of the À1606A allele, the PCR product (221 bp) was digested by KspAI into two fragments of 191 and 30 bp in length (À1606G undigested). In the presence of the À962del allele, the PCR product (339 bp) was digested by XapI into three fragments of 180, 93 and 66 bp in length. For À962ins, the PCR product (344 bp) was digested into four fragments of 180, 82, 66 and 16 bp in length, visualized on ethidium bromide-stained 3% agarose gels (primer sequences and digestion conditions are available upon request).
Statistical analysis
For database management and statistical analysis, we used SAS software, version 9.1.3 (SAS Institute, Cary, NC, USA). We compared means and proportions, using the large-sample z-test and the w 2 -statistic, respectively. Our statistical methods also included single and multiple linear regressions. We included in our models covariables with known physiological relevance to the left ventricular phenotypes under study, using stepwise multiple regressions with the significance level for independent variables to enter and stay in the model set at 0.15.
We performed both population-based and family-based analyses. As in earlier analyses, 7 we combined the least frequent homozygous group with the heterozygous subjects. We tested linkage disequilibrium, using the SAS procedure PROC ALLELE. We applied a generalization of the standard linear model, as implemented in the PROC MIXED procedure of the SAS package, to test the associations between phenotypes and single-nucleotide polymorphisms, while accounting for relatedness and adjusting for covariables. We tested for heterogeneity, using appropriate interaction terms with the genotypes.
In the family-based analysis, we performed transmission disequilibrium tests for quantitative traits (QTDT). We partitioned the phenotypic variance into between and within family components, using the orthogonal model 15 as implemented in Abecasis's QTDT software (version 2.6.0, available at http://www.sph.umich.edu/ csg/abecasis/QTDT). The within-family component of phenotypic variance reflects the genetic effect and is robust to population stratification.
RESULTS
Characteristics of the participants
The study population consisted of 1014 relatives from 252 families and 178 unrelated subjects. There was significant heterogeneity between the non-Slavic (Mirano and Hechtel-Eksel) and Slavic (Krakó w and Novosibirsk) participants in the association of MWT (P¼0.065) and LVMI (P¼0.012) with the SAH GÀ1606A polymorphism. Moreover, non-Slavic and Slavic participants had different (Po0.0001) age (47.6 vs. 36.7 years), waist-to-hip ratio (0.86 vs. 0.83), pulse rate (66.0 vs. 70.7 beats per minute), urinary excretion of sodium (175.3 vs. 230.0 mmol day À1 ) and potassium (69.4 vs. 62.1 mmol day À1 ), and LVMI (87.5 vs. 94.9 g m À2 ). For these reasons, in keeping with earlier reports, 10 we stratified all analyses according to ethnicity. Tables 1 and 2 list the subjects' characteristics by SAH genotypes for non-Slavic and Slavic participants, respectively. In both non-Slavic and Slavic subjects, LVMI increased with age ( Figure 1 ). Table 3 reports the genotype and allele frequencies of the two SAH polymorphisms. The À1606A allele frequencies were 11.7 and 12.1% in non-Slavic and Slavic participants, respectively (P for difference between ethnicities, 0.80). The frequency of the À962del allele was higher in non-Slavic than Slavic subjects (30.4 vs. 26.0%; P¼0.02).
Genotype frequencies
In all four centers, the frequencies of the GÀ1606A and À962ins/del genotypes were complied with Hardy-Weinberg proportions (0.20oPo0.59 and 0.14oPo0.98, respectively), except for the GÀ1606A genotypes in Krakó w (P¼0.02). The two SAH polymorphisms were in complete linkage disequilibrium. Lewontin's disequilibrium coefficient D' was 1.00 (Po0.0001). Population-based association study As in earlier analyses, 10, 11 we adjusted the left ventricular phenotypes for center, sex, age, systolic blood pressure, body weight and height, waist-to-hip ratio, pulse rate, use of antihypertensive drugs and lifestyle factors, including smoking and alcohol consumption in excess of 5 g per day. Models with LVMI as the dependent variable were not adjusted for body weight and body height. With these adjustments applied, in both non-Slavic and Slavic participants, we did not detect any heterogeneity between single centers in the relations between the left ventricular phenotypes and the GÀ1606A and À962ins/del polymorphisms.
In non-Slavic participants (Table 4) , the multivariable-adjusted mixed model showed a slightly greater (P¼0.080) LVID in À1606GG homozygotes than in À1606A allele carriers. Furthermore, non-Slavic À962del carriers, compared with À962ins homozygotes, had higher LVMI (P¼0.03) and MWT (P¼0.03). In Slavic participants (Table 4 ), À1606A allele carriers had higher LVMI (P¼0.004) and higher MWT (P¼0.003) than À1606GG homozygotes.
Family-based association study Our family-based analyses included 651 offspring and 541 parents (including unrelated subjects). We adjusted the QTDT analyses, as described above. Table 5 lists the between-family and within-family effect sizes associated with the GÀ1606A and À962ins/del polymorphisms. In non-Slavic participants, the between-family component of variance in LVID was significant for the GÀ1606A polymorphisms (P¼0.005), and transmission of the À962del to informative offspring was associated with higher MWT (P¼0.03). In Slavic subjects, the between-family component of variance in MWT was borderline significant (P¼0.055) for the À962ins/del polymorphism. Transmis- sion of the À962del to Slavic offspring was associated with decreased MWT (P¼0.007).
Sensitivity analyses
Among non-Slavic participants, the 24-h urinary sodium excretion was lower in Hechtel-Eksel than in Mirano (169.7 vs. 184.8 mmol day À1 ; P¼0.008). Adding a genotype-by-sodium interaction term to the multivariable-adjusted mixed model enhanced the significance of the association between LVID and the GÀ1606A polymorphism (effect size in carriers of the À1606A allele, À2.19 mm; P¼0.02). The interaction term was borderline significant (P¼0.07). It indicated that a 100 mmol day À1 higher sodium excretion was associated with a 0.57 mm increase in LVID in À1606A allele carriers, but with a 0.30 mm decrease in À1606GG homozygotes. Among 231 Slavic founders (Figure 2 ), À1606A allele carriers had higher LVMI (115.8 vs. 107.4 g m À2 ; P¼0.009) and higher MWT (11.6 vs. 11.1 mm; P¼0.005) than À1606GG homozygotes. Among 262 Slavic offspring, these phenotype-genotype associations were not significant. The multivariable-adjusted estimates (À1606A carriers vs. À1606GG homozygotes) were 87.8 vs. 85.8 g m À2 (P¼0.37) for LVMI and 9.3 vs. 9.1 mm (P¼0.20) for MWT.
Among Slavic founders, the À962ins/del genotype did not have any significant association with the left ventricular phenotypes; the multivariable-adjusted estimates (À962del carriers vs. À962ins homozygotes) were 110.6 vs. 108.8 g m À2 (P¼0.51) for LVMI and 11.3 vs. 11.2 mm (P¼0.41) for MWT. In contrast, in Slavic offspring, À962del carriers had lower LVMI (83.9 vs. 87.4 g m À2 ; P¼0.07) and MWT (8.8 vs. 9.3; P¼0.0003) than À962ins homozygotes (Figure 2 ).
DISCUSSION
The key finding of our study was that in multivariable-adjusted analyses, which also accounted for relatedness, LVMI and MWT were associated with genetic variation in the human SAH gene. However, there was heterogeneity in the phenotype-genotype associations between non-Slavic and Slavic participants. Indeed, in nonSlavic participants, À962del carriers had higher LVMI and MWT than À962ins homozygotes. Transmission of the À962del to non-Slavic offspring was also associated with higher MWT. In Slavic participants, À1606GG homozygotes had lower LVMI and lower MWT than À1606A carriers, but the latter association was confined to founders. Transmission of the À962del allele to Slavic offspring was associated with lower MWT. These findings underscore that phenotype-genotype associations can only be reasonably investigated, while accounting for ecogenetic context. 16, 17 We stratified our analyses of the phenotype-genotype associations according to ethnicity, because of the differences between non-Slavic and Slavic subjects in LVMI, anthropometric characteristics, sodium excretion and the frequency of the À962ins/del genotypes. In earlier reports, we already noticed ethnic diversity between Italian and Slavic populations in the frequencies of the AGTR2 G1675A, 11 ACE del/ins 10 and AGT C-532T 18 polymorphisms. In the latter study, 18 Slavic compared with Italian subjects also had higher LVMI. Other investigators reported ethnic diversity between western European and Slavic populations in various genetic polymorphisms, [19] [20] [21] which is probably due to differing genetic evolution along the migration patterns when Europe started to be populated from the Middle East and North Africa. [22] [23] [24] Research into the SAH gene found its roots in studies of genes, which are overexpressed in genetically hypertensive rats. 1, 25 The Suita population survey 6, 26 and subsequent case-control studies 4, 5, 14 reported significant associations of hypertension and related phenotypes, such as obesity, hypercholesterolemia and hypertriglyceridemia, with genetic variation in the SAH gene. Telgmann et al. 14 identified five polymorphisms in the SAH promoter region (CÀ1808T, GÀ1606A, À962ins/del, GÀ451A, TÀ67C), two polymorphisms in introns 5 and 7 (C+9/In5T, A+20/In7T) and one non-functional missense variant (K359N). In the PEGASE (Project d'Etude des Gènes de l'Hypertension Artérielle Sévère à Modérée Essentielle) case-control study for essential hypertension, Telgmann et al. 14 reported association between obesity-related hypertension and the SAH GÀ1606A and À962ins/del polymorphisms. However, we recently analyzed blood pressure, measures of obesity, serum lipids and blood glucose as continuous phenotypes in 2603 relatives from 560 families and 31 unrelated subjects randomly recruited from six populations in the framework of the EPOCH. We also genotyped the GÀ1606A and À962ins/del polymorphisms. In spite of sufficient statistical power, none of the phenotype-genotype associations approached statistical significance. 7 Left ventricular mass index and MWT depend on a complex interaction between genetic and environmental factors, including lifestyle. They increase with both blood pressure and body mass index. This might explain why, in our current analyses, we were able to show the association of these left ventricular phenotypes with variation in the SAH gene, whereas our earlier study was negative. 7 The PEGASE researchers 14 reported that carriers of the À1606A allele had higher blood pressure and increased body mass index compared with À1606GG homozygotes. Blood pressure and body mass index increase with advancing age. This might explain, why in our Slavic participants the association of LVMI and MWT with the GÀ1606A was confined to founders and why we did not pick it up in the familybased analysis of offspring. In our analyses of non-Slavic subjects, we noticed that LVID was slightly greater in À1606GG than À1606A carriers. In the family-based analyses, the between-family component of phenotypic variation in LVID was significant, whereas the within-family component was not. The between-family component reflects population stratification or admixture, whereas the within-family component reflects the genetic effect and is robust against population substructure. The 24-h urinary sodium excretion was 15.1 mmol day À1 lower in Belgians than in Italians. Adding a genotype-by-sodium interaction term to the multivariable-adjusted mixed model enhanced the significance of the association between LVID and the GÀ1606A polymorphism. This interaction term was borderline significant. Thus, we suggest that the association in the non-Slavic participants between LVID and the GÀ1606A polymorphism might reflect population stratification, possibly explained by differences in sodium intake.
We observed complete linkage disequilibrium between SAH GÀ1606A and À962ins/del polymorphisms. Using the PROC HAP-LOTYPE procedure as implemented in the SAS package, version 9.1.3., we inferred three haplotypes: the combinations of À1606G with À962ins (59.6%), À1606G with À962del (28.6%) and À1606A with À962ins (11.9%). The combination of À1606A with À962del did not exist. Studying the associations of the left ventricular phenotypes with the haplotypes did not produce any additional information, over and beyond the reported associations with single-nucleotide polymorphisms (data not shown).
Our study has to be interpreted within the context of its limitations. First, our sample size was relatively small and we only studied White Europeans of non-Slavic and Slavic origin. Our results might therefore not be generalizable to other ethnic groups. Second, LVM is a quantitative trait prone to measurement error. However, in each center only one experienced observer performed all ultrasound examinations. As reported elsewhere, 18 the intra-observer intersession reproducibility coefficient, computed according to Bland and Altman's method, 27 was less than 3% across centers. Third, the differences between genotypes in MWT and LVID were small. However, in the population-based analysis of the G-1606A polymorphism, the difference in LVMI was 5.8 g m À2 . In the family-based analysis, the effect size associated with -962del transmission was 3.33 g m À2 . These estimates represent 41.4% and 23.8% of the first-year changes in LVMI on blood pressure-lowering treatment in the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) trial. 28 In conclusion, our population-based and family-based studies showed that LVMI and MWT, two phenotypes that are jointly influenced by blood pressure and obesity, might be related to the variation in the human SAH gene. However, pending confirmation in other cohorts, the mechanisms underlying such association still need to be clarified in future research.
